Drugs Details

Drugs Info of Healon
Drugs Details
  • Drugs Type  : FDA
  • Date : 13th Jul 2015 04:34 am
  • Brand Name : Healon
  • Generic Name : Healon (sodium hyaluronate)

Healon (sodium hyaluronate) is a sterile, nonpyrogenic, viscoelastic preparation of a highly purified, noninflammatory, high molecular weight fraction of sodium hyaluronate.

Healon contains 10 mg/mL of sodium hyaluronate dissolved in physiological sodium chloride phosphate bufferlpH 7.0-7.51. This high molecularweight polymeris made up of repeating disaccharide units of N-acetyl-glucosamine and sodium glucuronate linked by b 1-3 and b 1-4 glycosidic bonds.


Healon (sodium hyaluronate) is indicated for use as a surgical aid in cataract extraction (intra- and extracapsular), IOL implantation, corneal transplant, glaucoma filtration and retinal attachment surgery.

In surgical procedures in the anterior segment of the eye, instillation of Healon (sodium hyaluronate) serves to maintaina deep anterior chamber during surgery, allowing for efficient manipulation with less trauma to the corneal endothelium and other surrounding tissues.

Furthermore, its viscoelasticity helps to push back the vitreous face and prevent formation of a postoperative flat chamber.

In posterior segment surgery Healon (sodium hyaluronate) serves as a surgical aid to gently separate, maneuver and hold tissues. Healon (sodium hyaluronate) creates a clear field of vision thereby facilitating intra- and postoperative inspection of the retina and photocoagulation.

Dosage Administration


Cataract Surgery-IOL Implantation

A sufficient amount of Healon (sodium hyaluronate) is slowly, and carefully introduced (using a cannula or needle into the anterior chamber.

Injection of Healon (sodium hyaluronate) can be performed either before or after delivery of the lens. Injection prior to lens delivery will, however, have the additional advantage of protecting the corneal endothelium from possible damage arising from the removal of the cataractous lens.5 Healon (sodium hyaluronate) may also be used to coat surgical instruments and the IOL prior to insertion.

Additional Healon (sodium hyaluronate) can be injected during surgery to replace any Healon (sodium hyaluronate) lost during surgical manipulation(see PRECAUTIONS section).

Glaucoma Filtration Surgery

In conjunction with performing of the trabeculectomy, Healon (sodium hyaluronate) is injected slowly and carefully through a corneal paracentesis to reconstitute the anterior chamber. Further injection of Healon (sodium hyaluronate) can be continued allowing it to extrude into the subconjunctival filtration site and through and around the sutured outer scleral flap.

Corneal Transplant Surgery

After removal of the corneal button, the anterior chamber is filled with Healon (sodium hyaluronate) . The donor graft can then be placed on top of the bed of Healon (sodium hyaluronate) and sutured in place. Additional Healon (sodium hyaluronate) maybe injected to replace the Healon (sodium hyaluronate) lost as a result of surgical manipulation (see PRECAUTIONS section). Healon (sodium hyaluronate) has also been used in the anterior chamber of the donor eye prior to transplantation to protect the corneal endothelial cells of the graft 5 .

Retinal Attachment Surgery

Healon (sodium hyaluronate) is slowly introduced into the vitreouscavity. By directing the injection, Healon (sodium hyaluronate) can be used to separate membranes (e.g. epiretinal membranes) away from the retina for safe excision and release of traction. Healon (sodium hyaluronate) also serves to maneuver tissues into the desired position, e.g. to gently push back a detached retina or unroll a retinal flap. and aids in holding the retina against the sclera for reattachment.


How Supplied

Healon (sodium hyaluronate) is a sterile, nonpyrogenic, viscoelastic preparation supplied in disposable glass syringes, delivering 0.85 mL, 0.55 mL or 0.4 mL sodium hyaluronate MO mg/mL dissolved in physiological sodium chloride phosphate buffer( pH 7.0-7.5). Each mL of Healon contains 10 mg of sodium hyaluronate, 8.5 mg sodium chloride, 0.28 mg of disodium hydrogen phosphate dihydrate, 0.04 mg of sodium dihydrogen phosphate hydrate and q.s. water for injection U.S.P. Healon (sodium hyaluronate) syringes are terminally sterilized and aseptically packaged.

A sterile single - use 27 G cannula is enclosed in the 0.4 mL,0.55 mL, and 0.85 mL boxes.

Refrigerated Healon (sodium hyaluronate) should be allowed to attain room temperature (approximately 30 minutes) prior to use.

For intraocular use.

Store at 2 to 8 ° C (35 to 47 ° F).

Protect from freezing.

Protect from light.


Federal law restricts this device to sale by or on the order of a physician.


1. Richter, W., Ryde, M. Zetterstrom, O.: Nonimmunogenicity of a purified sodium hyaluronate preparation in man. Int Arch Appl Immun 59:45-48(1979).

2. Balazs, E. A.: Ultrapure hyaluronic acid and the use thereof. U.S. Patent 4,141, 973(1979).

3. Balazs, E. A., Miller, D & Stegmann, R.: Viscosurgery and the use of Na-hyaluronate in intraocular lens implantation. Lecture, Cannes, France(1979).

4. Miller, D.& Stegmann, R: Use of Na-hyaluronate in anterior segment eye surgery. Am Intra-Ocular Implant Soc J 6 (980b) p 13-15.

5. Pape, L. G.& Balazs, E. A.: The use of sodium hyaluronate (Healon (sodium hyaluronate) ®) in human anterior segment surgery. Ophthalmol 87 (1980) p 699-705.

Side Effects

Healon (sodium hyaluronate) is extremely well tolerated after injection into human eyes. A transient rise of intraocular pressure postoperatively has been reported in some cases.

In posterior segment surgery intraocular pressure rises have been reported in some patients, especially in aphakic diabetics, after injection of large amounts of Healon (sodium hyaluronate) .

Rarely, postoperative inflammatory reactions liritis, hypopyon as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to Healon (sodium hyaluronate) has not been established.


No information provided.


No information provided.


Those normally associated with the surgical procedure being performed.

Over filling the anterior or posterior segment of the eye with Healon (sodium hyaluronate) may cause increased intraocular pressure, glaucoma, or other ocular damage.

Postoperative intraocular pressure may also be elevated as a result of pre-existing glaucoma, compromised outflow and by operative procedures and sequelae thereto, including enzymatic zonulysis, absence of an iridectomy, trauma to filtration structures, and by blood and lenticular remnants in the anterior chamber. Since the exact role of these factors is difficult to predict in any individual case, the following precautions are recommended:

Don't overfill the eye chambers with Healon (sodium hyaluronate) (except in glaucoma surgery.(See DOSAGE AND ADMINISTRATION: Applications).

. In posterior segment procedures in aphakic diabetic patients special care should be exercised to avoid using large amounts of Healon (sodium hyaluronate) .

Remove some of the Healon (sodium hyaluronate) by irrigation and/or aspiration at the close of surgery (except in glaucoma surgery - See DOSAGE AND ADMINISTRATION: Applications).

Carefully monitor the intraocular pressure, especially during the immediate postoperative period. If significant rises are observed, treat with appropriate therapy.

Care should be taken to avoid trapping air bubbles behind Healon (sodium hyaluronate) .

Because Healon (sodium hyaluronate) is a highly purified fraction extracted from avian tissues and is known to contain minute amounts of protein, the physician should be aware of potential risks of the type that can occur with the injection of any biological material.

Because of reports of an occasional release of minute rubber particles, presumably formed when the diaphragm is punctured, the physician should be aware of this potential problem. Express a small amount of Healon (sodium hyaluronate) from the syringe prior to use, and carefully examine the remainder as it is injected.

Avoid reuse of cannulas. If reuse becomes necessary, rinse cannula thoroughly with sterile distilled water.

Sporadic reports have been received indicating that Healon (sodium hyaluronate) may become "cloudy" or form a slight precipitate following instillation into the eye. The clinical significance of these reports, if any, is not known since the majority received to date do not indicate any harmful effects on ocular tissues. The physician should be aware of this phenomenon and, should it be observed, remove the cloudy or precipitated material by irrigation and/or aspiration.

In vitro laboratory studies suggest that this phenomenon may be related to interactions with certain concomitantly administered ophthalmic medications.

Use only if solution is clear.


No information provided.


At present there are no known contraindications to the use of Healon (sodium hyaluronate) when used as recommended.

Clinical Pharamacology


Sodium hyaluronate is a physiological substance that is widely distributed in the extracellular matrix of connective tissues in both animals and man. For example, it is present in the vitreous and aqueous humor of the eye, the synovialfluid, the skin and the umbilical cord. Sodium hyaluronates prepared from various human and animal tissues are not chemically different from each other.

Healon is a specific fraction of sodium hyaluronate developed as an ophthalmo-surgical aid for use in anterior segment and vitreous procedures. It is specific in that:

1. It has a high molecular weight.

2. It is reported to be nonantigenic 1, 6

3. It does not cause inflammatory 2 or foreign body reactions.

4. It has a high viscosity.

Furthermore, the 1% solution of Healon (sodium hyaluronate) is transparent, is reported to remain in the anterior chamber for less than 6 days3 and protects corneal endothelial cells4, 5 and other ocular structures. Healon (sodium hyaluronate) does not interfere with epithelialization and normal wound healing.

Patient Information


Sterile opening technique

Tear off the paper covering.

Bend the plastic backwards at the central indentation so as to fully expose the white plastic rod.

Dislodge syringe and place onto sterile field.


Press the vial completely into the holder so that the needle perforates the membrane.


Perforate the membrane before screwing on the plastic rod.

Remove the plastic rod.

Screw the plastic rod into the blue plunger.

Connect the cannula and check for proper function.

Store at 2 to 8° C (35 to 47° F). For single use only

Consumer Overview Uses

No Information Available!

Consumer Overview Side Effect

No Information Available!

Consumer Overview Missed Dose

No Information Available!

Patient Detailed Side Effect

No Information Available!

Patient Detailed How Take

No Information Available!

Patient Detailed Avoid Taking

No Information Available!

Rx Scoops
Featured Topics
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI